Kardigan Sets IPO Price at $16, Aiming for $400M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- IPO Pricing Announcement: Kardigan has priced its initial public offering at $16 per share for 25 million shares, projecting total gross proceeds of $400 million, indicating strong market demand for its cardiovascular therapies.
- Increased Financing Target: Originally planning to sell 23.3 million shares to raise approximately $350 million, the expansion of the offering reflects investor confidence and the potential of Kardigan's market, raising the target to $400 million.
- Trading Schedule: The company's stock is set to begin trading on June 18, 2026, on the Nasdaq Global Market, with the offering expected to close on June 22, 2026, subject to customary regulatory conditions.
- Underwriting Syndicate: J.P. Morgan, Jefferies, Leerink Partners, and TD Securities are serving as joint book-running managers for the offering, enhancing market trust and support for Kardigan's IPO.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
